UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Details
Sales, net	$ 13,428	$ 12,604	$ 25,752	$ 23,568
Cost of goods sold	5,277	4,819	10,069	8,836
Gross profit	8,151	7,785	15,683	14,732
Operating expense
Selling, general and administrative	2,959	2,892	5,846	5,821
Research & development	135	128	258	259
Total operating expenses	3,094	3,020	6,104	6,080
Operating income	5,057	4,765	9,579	8,652
Other income	142	60	150	71
Income before provision for income taxes	5,199	4,825	9,729	8,723
Provision for income taxes	1,096	1,399	2,091	2,273
Net income	$ 4,103	$ 3,426	$ 7,638	$ 6,450
Earnings per common share (basic)	$ 1.13	$ 0.94	$ 2.09	$ 1.77
Earnings per common share (diluted)	$ 1.12	$ 0.94	$ 2.09	$ 1.76
Shares outstanding - basic	3,643	3,646	3,649	3,645
Shares outstanding - diluted	3,650	3,655	3,658	3,656
Other comprehensive income (loss)
Foreign currency translation net of taxes of $0 in all periods	$ (2,298)	$ 49	$ (2,804)	$ (5)
Total comprehensive income	$ 1,805	$ 3,475	$ 4,834	$ 6,445